• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In Silico Design of New Inhibitors Against Hemagglutinin of Influenza

tetano

Editor, Senior Moderator
J Phys Chem B. 2018 Dec 28. doi: 10.1021/acs.jpcb.8b10767. [Epub ahead of print]
[h=1]In Silico Design of New Inhibitors Against Hemagglutinin of Influenza.[/h] Perrier A, Eluard M, Petitjean M, Vanet A.
[h=3]Abstract[/h] The RNA virus Influenza A is a serious public health problem with every year epidemics resulting in more than 250,000 deaths. A target zone was identified on the HA2 subunit of the hemagglutinin responsible for the entry of the virus into the host cell by endocytosis. The binding of a ligand in this zone rich in invariant residues and synthetic lethal couples, could prevent therapeutic escape and inhibit the conformational change at pH=5 initiating the membrane fusion in the endosome. Two pentapeptides, a linear peptide (EQRRS) and a cyclic peptide (DQRRD) have been proposed as potential drugs. Complex stability and the interactions between the ligand and the protein have been studied with the help of molecular dynamics and quantum chemistry methods. A high stability of the interactions has been obtained for these two ligands at both pH=7 and pH=5. Indeed, these two peptides present two cooperative modes of action that should prevent the conformational change at the origin of the spring-loaded mechanism at pH=5, (1) mechanical since they are docked on HA2, and (2) electronic since they modify the protonation states of key residues in the hairpin zone. This study thus paves the way towards the development of peptide drugs that can inhibit the membrane fusion process.


PMID: 30590925 DOI: 10.1021/acs.jpcb.8b10767
 
Back
Top Bottom